Flow Health Science Named Start-Up of the Month by FoodBev Media

London, UK – Flow Health Science has been named Start-Up of the Month by FoodBev Media, one of the leading trade publications covering the global food and beverage industry. The feature focuses on Klario®, the company's flagship hypo recovery product, and the broader vision behind Flow Health Science's approach to clinically proven advanced nutrition.

The recognition reflects a broader shift in how the industry is thinking about the boundary between food and medicine. FoodBev Media selected Flow Health Science precisely because Klario sits at that intersection — retaining the accessibility of a consumer product while applying a level of scientific rigour more typical of pharmaceuticals. For Flow Health Science, that positioning is deliberate: the company's model is built on identifying specific unmet clinical needs, developing purpose-built products, and generating high-quality evidence to support them.

“FoodBev's online 'Start-up of the month' series showcases innovative start-ups and smaller businesses within the global food and beverage industry who are working to deliver unique products and bold ideas that respond to untapped opportunities. We thought Flow Health Science was a perfect fit, having recently won the Best Health Innovation award at the World Food Innovation Awards 2026 for its flagship Klario hypo recovery product. The company builds its innovation around responding to real unmet needs in the nutrition sector, developing science-backed concepts with health at the centre.” — Melissa Bradshaw, Group Editor, FoodBev Media

Klario was developed for people with type 1 diabetes who experience hypoglycemia and its often-debilitating aftermath: brain fog, fatigue, and a prolonged inability to return to normal activities. Klario combines fast-acting carbohydrates with additional adaptive energy substrates to support recovery beyond glucose restoration alone.

In a peer-reviewed 12-week randomised study analysing more than 1,000 real-world hypoglycemic episodes, Klario was associated with a 27% reduction in recurrent hypoglycemia and helped participants return to normal daily activities faster than glucose-only products. The study was published in Diabetes, Obesity and Metabolism and presented at the Diabetes UK Professional Conference 2026.

“FoodBev Media naming us Start-Up of the Month is a sign that the industry is ready for change. We're not building products around broad wellbeing claims, we're bringing scientific rigour to daily care to address the gap between supplements and therapies.” — Tara Lumley, Chief Strategy Officer at Flow Health Science

Klario represents the first product in a planned portfolio. Flow Health Science is applying the same development approach to programmes in oncology, endocrinology, and performance; areas where the company sees significant unmet need and a compelling case for nutrition-based intervention backed by clinical evidence.

The full FoodBev Media feature is available here. Klario® is available now at www.myklario.com.

About the Product

---

Klario®: A Novel Approach to Hypoglycaemia Management

Hypoglycemia represents a critical therapeutic challenge in diabetes management: people with T1D may experience 100–200 treatment-related episodes annually. Current recommended therapeutic interventions using glucose-only treatments frequently result in suboptimal outcomes, including rapid glucose fluctuations, persistent neuroglycopenic symptoms, and fear-driven non-adherence to medication. Klario, a novel multi-substrate energy formulation combining glucose with BHB, was designed to achieve more complete recovery from hypoglycemia. In line with medical guidelines, Klario delivers 15 grams of fast-acting carbs to raise blood glucose quickly, while also raising BHB levels acutely. This combination formula improves glycemic control in the immediate post-treatment period and provides rapid, sustained neuroglycopenic recovery. For more information about Klario, please visit myklario.com.